{"filing":{"accession_number":"0001493152-26-040324","cik":"0001178697","ticker":"SONM","company_name":"DNA X, Inc.","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-21","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226040324/form8-k.htm"},"events":[{"id":29906,"run_id":27404,"accession_number":"0001493152-26-040324","anchor_item_number":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The filing discloses approval by the compensation committee of cash awards to all board members, including CEO Mike Mulica, in lieu of RSU grants under the 2019 Equity Incentive Plan. The awards are structured as \"Substitute Cash Grants\" valued at $60,000 per director, vesting upon the 2027 annual meeting or a change in control. This is a compensatory arrangement for directors and officers that materially affects their compensation structure and would be relevant to investors assessing executive pay practices.","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":32342,"accession_number":"0001493152-26-040324","item_number":null,"item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses approval by the compensation committee of cash awards to all board members, including CEO Mike Mulica, in lieu of RSU grants under the 2019 Equity Incentive Plan. The awards are structured as \"Substitute Cash Grants\" valued at $60,000 per director, vesting upon the 2027 annual meeting or a change in control. This is a compensatory arrangement for directors and officers that materially affects their compensation structure and would be relevant to investors assessing executive pay practices.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:33:43.802602+00:00","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-08-27"}]}